Filing Details
- Accession Number:
- 0000950170-23-023509
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-05-22 18:47:11
- Reporting Period:
- 2023-05-18
- Accepted Time:
- 2023-05-22 18:47:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1521036 | Lantheus Holdings Inc. | LNTH | In Vitro & In Vivo Diagnostic Substances (2835) | 352318913 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1801395 | Paul Blanchfield | C/O Lantheus Holdings, Inc. 201 Burlington Road, South Building Bedford MA 01730 | President | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-05-18 | 1,500 | $97.93 | 92,743 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-05-18 | 250 | $0.00 | 92,493 | No | 4 | G | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | G | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 24, 2023.
- Reduced by 785 shares previously reported as disposed of in a Form 4 filed on May 17, 2022, but inadvertently included in the amount of securities reported in Column 5 of that previously filed Form 4.
Billionaire Hedge Funds
